American Vanguard Corp. (NYSE:AVD) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued on Monday.

According to Zacks, “AMERICAN VANGUARD CORP. is a holding company, which through its subsidiaries, is engaged in the manufacturer and formulation of chemicals for crops, human and animal health protection. These chemicals which include insecticides, fungicides, molluscicides, growth regulatorsain, and soil fumigants, are marketed in liquid, powder, and granular forms. “

Several other research firms have also weighed in on AVD. Piper Jaffray Companies upgraded shares of American Vanguard Corp. from an “underweight” rating to a “neutral” rating and upped their price objective for the company from $12.00 to $17.00 in a research note on Monday, November 28th. Roth Capital upgraded shares of American Vanguard Corp. from a “neutral” rating to a “buy” rating in a research note on Monday, January 23rd. Finally, Feltl & Co. reiterated a “strong-buy” rating on shares of American Vanguard Corp. in a research note on Wednesday, March 8th. Three analysts have rated the stock with a hold rating, two have given a buy rating and one has issued a strong buy rating to the company. The company has a consensus rating of “Buy” and a consensus price target of $17.50.

Analyst Recommendations for American Vanguard Corp. (NYSE:AVD)

Shares of American Vanguard Corp. (NYSE:AVD) traded up 0.64% during midday trading on Monday, reaching $15.75. 114,064 shares of the company were exchanged. American Vanguard Corp. has a 52-week low of $12.60 and a 52-week high of $20.00. The stock has a market capitalization of $462.86 million, a price-to-earnings ratio of 35.80 and a beta of 1.27. The company’s 50-day moving average price is $16.34 and its 200 day moving average price is $16.80.

American Vanguard Corp. (NYSE:AVD) last released its quarterly earnings data on Monday, March 6th. The company reported $0.13 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.12 by $0.01. The firm had revenue of $87.50 million for the quarter, compared to analyst estimates of $89.10 million. American Vanguard Corp. had a net margin of 3.86% and a return on equity of 4.36%. The company’s revenue for the quarter was up 4.8% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.10 EPS. On average, equities analysts predict that American Vanguard Corp. will post $0.62 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 14th. Stockholders of record on Friday, March 31st will be paid a dividend of $0.015 per share. This is a positive change from American Vanguard Corp.’s previous quarterly dividend of $0.01. The ex-dividend date of this dividend is Wednesday, March 29th. This represents a $0.06 annualized dividend and a dividend yield of 0.38%. American Vanguard Corp.’s dividend payout ratio is 9.76%.

Your IP Address:

In related news, CEO Eric G. Wintemute sold 10,000 shares of the firm’s stock in a transaction on Tuesday, February 7th. The shares were sold at an average price of $16.40, for a total value of $164,000.00. Following the transaction, the chief executive officer now directly owns 890,845 shares in the company, valued at approximately $14,609,858. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Eric G. Wintemute sold 20,000 shares of the firm’s stock in a transaction on Tuesday, January 17th. The shares were sold at an average price of $17.01, for a total transaction of $340,200.00. Following the completion of the transaction, the chief executive officer now owns 900,845 shares in the company, valued at $15,323,373.45. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 52,075 shares of company stock worth $847,705. 4.30% of the stock is currently owned by company insiders.

A number of hedge funds and other institutional investors have recently bought and sold shares of AVD. Catalyst Capital Advisors LLC purchased a new position in American Vanguard Corp. during the third quarter worth about $128,000. Wells Fargo & Company MN raised its position in American Vanguard Corp. by 44.9% in the third quarter. Wells Fargo & Company MN now owns 10,915 shares of the company’s stock worth $175,000 after buying an additional 3,381 shares during the last quarter. Hartford Investment Management Co. raised its position in American Vanguard Corp. by 18.3% in the third quarter. Hartford Investment Management Co. now owns 12,300 shares of the company’s stock worth $198,000 after buying an additional 1,900 shares during the last quarter. Susquehanna International Group LLP purchased a new position in American Vanguard Corp. during the third quarter worth about $292,000. Finally, Texas Permanent School Fund raised its position in American Vanguard Corp. by 0.3% in the third quarter. Texas Permanent School Fund now owns 19,675 shares of the company’s stock worth $316,000 after buying an additional 62 shares during the last quarter. Institutional investors and hedge funds own 78.59% of the company’s stock.

American Vanguard Corp. Company Profile

American Vanguard Corporation (AVD) operates as a holding company. The Company conducts its business through its subsidiaries, AMVAC Chemical Corporation (AMVAC), GemChem, Inc (GemChem), 2110 Davie Corporation (DAVIE), Quimica Amvac de Mexico SA de C.V. (AMVAC M), AMVAC Mexico Sociedad de Responsabilidad Limitada (AMVAC M Srl), AMVAC de Costa Rica Sociedad de Responsabilidad Limitada (AMVAC CR Srl), AMVAC Switzerland GmbH (AMVAC S), AMVAC do Brasil Representacoes Ltda (AMVAC B), AMVAC CV (AMVAC CV), AMVAC Netherlands BV (AMVAC BV) and Envance Technologies, LLC (Envance).

5 Day Chart for NYSE:AVD

Receive News & Stock Ratings for American Vanguard Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Vanguard Corp. and related stocks with our FREE daily email newsletter.